Skip to main content
Top
Published in: International Urology and Nephrology 10/2023

13-07-2023 | Cystitis | Urology - Original Paper

Does renal failure worsen radiation cystitis following radical prostatectomy?

Authors: Ricky Chen, Sikai Song, Akin S. Amasyali, Rose Leu, Kanha Shete, Cayde Ritchie, Matthew Buell, Catalina Baas, Joshua D. Belle, Daniel Jhang, Ala’a Farkouh, D. Duane Baldwin

Published in: International Urology and Nephrology | Issue 10/2023

Login to get access

Abstract

Objective

To investigate the impact of renal function on the risk, severity, and management of radiation cystitis in patients who underwent postoperative radiation therapy for prostate cancer.

Methods

Retrospective data was assessed from patients treated with adjuvant/salvage radiation therapy at a single academic institution between 2006 and 2020. The incidence, severity, and management of radiation cystitis were compared between three groups: CKD 0–2, CKD 3–4, and CKD 5. Associations of clinicopathologic factors with radiation cystitis were assessed in univariate and multivariate Cox regression models.

Results

A total of 110 patients who underwent radiation therapy following robot-assisted laparoscopic radical prostatectomy were included. The incidence of radiation cystitis following postoperative radiation therapy was 17% with a median presentation time of 34 months (interquartile range 16–65 months). The incidence of radiation cystitis was 100% in CKD 5 patients compared to 15% in CKD 0–2 and 17% in CKD 3–4 patients (p < 0.001). CKD 5 patients required more treatments, emergency department visits, and longer hospitalization times than CKD 0–4 patients (all p < 0.001). Multivariate analyses identified CKD 5 as the only significant factor associated with radiation cystitis (HR = 10.39, p = 0.026).

Conclusion

End-stage renal failure is associated with the risk and severity of radiation cystitis in patients receiving postoperative radiation therapy. Knowledge of the potential morbidity of this complication in this population could guide physicians and patients as they evaluate risks and benefits prior to selecting adjuvant or salvage radiation therapy.
Literature
3.
go back to reference Litwin MS, Tan H-J (2017) The diagnosis and treatment of prostate cancer: a review. JAMA 317(24):2532–2542CrossRefPubMed Litwin MS, Tan H-J (2017) The diagnosis and treatment of prostate cancer: a review. JAMA 317(24):2532–2542CrossRefPubMed
6.
go back to reference Browne C, Davis NF, Mac Craith E et al (2015) A narrative review on the pathophysiology and management for radiation cystitis. Adv Urol 20:15 Browne C, Davis NF, Mac Craith E et al (2015) A narrative review on the pathophysiology and management for radiation cystitis. Adv Urol 20:15
16.
go back to reference Helissey C, Cavallero S, Brossard C, Dusaud M, Chargari C, François S (2020) Chronic inflammation and radiation-induced cystitis: molecular background and therapeutic perspectives. Cells 10(1):21CrossRefPubMedPubMedCentral Helissey C, Cavallero S, Brossard C, Dusaud M, Chargari C, François S (2020) Chronic inflammation and radiation-induced cystitis: molecular background and therapeutic perspectives. Cells 10(1):21CrossRefPubMedPubMedCentral
18.
go back to reference Santos PMG, Barsky AR, Hwang WT et al (2019) Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting. Cancer 125(23):4278–4293CrossRefPubMed Santos PMG, Barsky AR, Hwang WT et al (2019) Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting. Cancer 125(23):4278–4293CrossRefPubMed
Metadata
Title
Does renal failure worsen radiation cystitis following radical prostatectomy?
Authors
Ricky Chen
Sikai Song
Akin S. Amasyali
Rose Leu
Kanha Shete
Cayde Ritchie
Matthew Buell
Catalina Baas
Joshua D. Belle
Daniel Jhang
Ala’a Farkouh
D. Duane Baldwin
Publication date
13-07-2023
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 10/2023
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03709-8

Other articles of this Issue 10/2023

International Urology and Nephrology 10/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine